Fannie Mae, Freddie Mac shares tumble after conservatorship comments
FREMONT, CA—Jonathan Bornstein, President of Amprius Lab, recently sold shares of Amprius Technologies, Inc. (NYSE:AMPX) worth approximately $42,382. The transaction involved the sale of 13,527 shares at an average price of $3.1332 per share. These sales were conducted on February 21, 2025, as part of a pre-arranged sell-to-cover arrangement to fulfill tax withholding obligations related to the vesting of restricted stock units. The sale comes amid significant stock volatility, with InvestingPro data showing a 17.46% decline in share price over the past week. The company, currently valued at $375 million, trades below its Fair Value according to InvestingPro’s analysis.
Following the transaction, Bornstein retains direct ownership of 419,197 shares. Additionally, 1,062,357 shares are held indirectly through the Jonathan G. Bornstein and Phyllis S. Brock Trust Agreement, where he and his spouse serve as co-trustees. For deeper insights into AMPX’s valuation metrics and 14+ additional ProTips, visit InvestingPro, where you’ll find comprehensive analysis in our exclusive Pro Research Report.
In other recent news, Amprius Technologies has caught the attention of Cantor Fitzgerald, which initiated coverage on the company with an Overweight rating and set a price target of $10.00. The decision follows significant advancements in Amprius’s manufacturing capabilities, particularly the successful implementation of a drop-in manufacturing process for its SiCore silicon anode cells in 2024. This innovation allows Amprius to produce high-quality battery cells without the need for a U.S.-based production facility, enabling the company to utilize third-party manufacturing resources effectively. Cantor Fitzgerald’s reassessment of Amprius’s prospects is based on these strategic shifts, which eliminate the financial and logistical challenges previously associated with establishing a gigawatt-scale facility in the U.S. The firm’s confidence in Amprius’s current trajectory is reflected in the favorable rating, highlighting the company’s ability to capitalize on its proprietary silicon anode technology. These recent developments position Amprius Technologies with a positive outlook as they continue to innovate within the battery technology sector.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.